biogen

Biogen (BIIB) Q3 2025 Earnings Call Transcript

Biogen (BIIB) Q3 2025 Earnings Call Transcript

By
October 30, 2025
Biogen (BIIB) Q2 2025 Earnings Call Transcript

Biogen (BIIB) Q2 2025 Earnings Call Transcript

By
July 31, 2025
Biogen (BIIB) Q1 2025 Earnings Call Transcript

Biogen (BIIB) Q1 2025 Earnings Call Transcript

By
May 1, 2025
Biogen (BIIB) Q4 2024 Earnings Call Transcript

Biogen (BIIB) Q4 2024 Earnings Call Transcript

By
February 12, 2025
A young woman undergoes a brain scan.

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

By
February 6, 2025
FDA
Health

First-of-its-kind drug for rare form of Lou Gehrig’s disease gets FDA approval

By Matthew Perrone and The Associated Press
April 25, 2023
FDA headquarters
Health

Alzheimer’s drug approval by FDA ‘rife with irregularities,’ Congress finds after 18-month investigation

By
December 30, 2022
A pedestrian walks by Biogen's headquarters
Health

Congressional investigators say the FDA’s controversial approval of Biogen’s Alzheimer’s drug Aduhelm was ‘rife with irregularities’

By Fiona Rutherford, Celine Castronuovo and Bloomberg
December 30, 2022
Breakthrough Alzheimer’s trial results show experimental drug significantly slows the disease
Health

Breakthrough Alzheimer’s trial results show experimental drug significantly slows the disease

By Michelle Fay Cortez and Bloomberg
September 28, 2022
Elderly man holding his medicine
Health

Inside the lobbying push to get Medicare to pay for a controversial Alzheimer’s drug

By Arthur Allen and Kaiser Health News
February 16, 2022
Biogen building
Health

Medicare ordered to reassess premium hike for Alzheimer’s drug

By Ricardo Alonso-Zaldivar and The Associated Press
January 10, 2022
Biogen headquarters
Health

Biogen slashes cost of Alzheimer’s drug by 50% six months after FDA approval

By Timothy Annett and Bloomberg
December 20, 2021
The spread of the ‘Delta Plus’ subvariant is a reminder of where visions of our COVID future diverge
Newsletters

The spread of the ‘Delta Plus’ subvariant is a reminder of where visions of our COVID future diverge

By
November 18, 2021
Capsule-Doctors Covid Myths
Newsletters

Medical boards are still struggling to discipline doctors who spread COVID-19 myths

By
November 11, 2021
Medicare-Prescription Pill Box
Newsletters

Medicare negotiating drug prices could be the game changer Americans need

By
November 4, 2021

Most Popular